Frequency of metabolic syndrome in patients of chronic plaque psoriasis
Abstract
ABSTACT Background Psoriasis is a common, chronic, inflammatory condition of the skin. The incidence of metabolic syndrome is three times higher in psoriasis which has significant and serious implications on the health of patient overall health and life span.  Objective To determine the frequency of metabolic syndrome in patients of chronic plaque psoriasis.  Methods It was a Cross sectional study conducted in department of Dermatology, Services Hospital, Lahore on 150 patients were enrolled. All enrolled patients were tested for their fasting blood sugar, fasting lipid levels, postprandial blood sugar, serum cholesterol, and triglycerides levels. Plasma glucose was measured using glucose oxidase method and serum lipids with enzymatic assays. Waist circumference was measured. Blood pressure was recorded. Outcome variable i.e. metabolic syndrome was recorded.  Results The mean age of the patients was 49.23±17.59 years, 114 (76%) patients were male and 117 (78%) patients were married. The familial dyslipidemia was detected in 15 (10%) patients and the metabolic syndrome was found in 49 (32.67%) patients.  Conclusion This study concluded that in patients of chronic plaque psoriasis approximately one third of the patients are with metabolic syndrome. ÂReferences
Burden AD, Kirby B. Psoriasis and related disorders. Rook's Textbook of Dermatology, Ninth Edition 2016:35.1-64.
De Brandt E, Hillary T. Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management. Psoriasis (Auckl). 2022;12:113-26
Branisteanu, D. E., Pirvulescu, R. A., Spinu, A. E., Porumb, E. A., Cojocaru, M., Nicolescu, et al. Metabolic comorbidities of psoriasis (Review). Exp Ther Med.2022; 23(2):179.
Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-35.
Mhusakunchai P, Techasatian L. An Association of Pediatric Psoriasis with Metabolic Syndrome in Thai Children: 20 Years Retrospective Study. Psoriasis (Auckl). 2021;11:75-82.
Xu, Cheng1; Ji, Jie; Su, Ting; Wang, Hong-Wei; Su, Zhong-Lan. The Association of Psoriasis and Obesity: Focusing on IL-17A-Related Immunological Mechanisms. Int J Dermatol. 2021;4(2):116-21.
Paroutoglou, K., Papadavid, E., Christodoulatos, G.S. et al. Deciphering the Association Between Psoriasis and Obesity: Current Evidence and Treatment Considerations. Curr Obes Rep. 2020;9(3): 165–78.
Lakshmi S, Nath AK, Udayashankar C. Metabolic syndrome in patients with psoriasis: A comparative study. Indian Dermatol Online J.2014;5(2):132.
MilÄić D, Janković S, Vesić S, Milinković M, Marinković J, Ćirković A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol. 2017;92(1):46-51.
Praveenkumar U, Ganguly S, Ray L, Nanda SK, Kuruvila S. Prevalence of metabolic syndrome in psoriasis patients and its relation to disease duration: a hospital based case-control study. J Clin Diagn Res: 2016;10(2):WC01.
Ghias A, Khan MS, Shaheen E. Frequency of metabolic syndrome in patients of psoriasis. J Pak Assoc Dermatol. 2018;28(1):73-8.
Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospitalâ€based case–control study. Br J Dermatol.2007;157(1):68-73.
Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol. 2011;147(4):419-24.
Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol.2010;76(6):662.
Cohen A, Sherf M, Vidavsky L, Vardy D, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. Dermatology. 2008;216(2):152-5.
Akhyani M, Ehsani A, Robati R, Robati A. The lipid profile in psoriasis: a controlled study. J Eur acad Dermatol Venereol. 2007;21(10):1330-2.
Solak Tekin N, Tekin IO, Barut F, Yilmaz Sipahi E. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients. Mediators of inflammation. 2007;2007.
Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, et al. Psoriasis and the metabolic syndrome. Acta Derm Venereol. 2007;87(6):506-9.
Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol. 2007;56(4):629-34.
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2007;298(7):321.
Ferdinando LB, Fukumoto PK, Sanches S, Fabricio LHZ, Skare TL. Metabolic syndrome and psoriasis: a study in 97 patients. Revista da Associação Médica Brasileira. 2018;64(4):368-73.
Arias-Santiago S, Orgaz-Molina J, Castellote-Caballero L, Arrabal-Polo MÃ, GarcÃa-Rodriguez S, Perandrés-López R, et al. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis. Eur J Dermatol. 2012;22(3):337-44.
Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. 2012;132(3):556-62.
Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640-5.
Khunger N, Gupta D, Ramesh V. Is psoriasis a new cutaneous marker for metabolic syndrome? A study in Indian patients. Indian J Dermatol. 2013;58(4):313.
Madanagobalane S, Anandan S. Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study. Indian J Dermatol. 2012;57(5):353.
Pereira RR, Amladi ST, Varthakavi PK. A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis. Indian J Dermatol. 2011;56(5):520.
Gopal M, Talwar A, Sharath Kumar B, Ramesh M, Nandini A, Meena H. A clinical and epidemiological study of psoriasis and its association with various biochemical parameters in newly diagnosed cases. J Clin Diagn Res: 2013;7(12):2901.
Salunke AS, Nagargoje MV, Belgaumkar VA, Tolat SN, Chavan RB. Association of metabolic syndrome in chronic plaque psoriasis patients and their correlation with disease severity, duration and case control study from Western Maharashtra. J Clin Diagn Res. 2017;11(8):WC06.
